Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. The war with Iran has driven oil prices up, prompting concern that the supply of some medicines will be disrupted. In a new report, Unitaid emphasized that essential medicines are exposed to oil price volatility. Specifically, the global health agency examined the effect rising oil prices could have on one HIV medication and found that manufacturing costs could rise by 15% if oil reaches $120 per barrel, and 85% of those higher costs are driven by petrochemical ingredients. AdvertisementAs part of our access strategy, we have a climate and health strategy that looks into ways in which basically we can just advance product knowledge that’s good for health, but also good for climate.